Preserve surgical excellence – Improve patient outcomes

Product Overview

Dynavisc is intended to be applied around tendons, ligaments, and skeletal muscle following tendon surgery to provide a temporary physical barrier that separates and protects these tissues during the healing process.

Dynavisc gel is supplied sterile, ready to use in a 2.5 mL or 1 mL syringe with a flexible applicator.

Improved Outcomes

Dynavisc gel has demonstrated in preclinical and clinical studies1-4 to improve functional outcomes, preserve tissue gliding, and support tendon healing.

Established Clinical History

With 15 years of clinical use, Dynavisc has an established clinical history in more than 50,000 procedures worldwide and supported by multiple clinical studies.

Our proprietary dual-polymer formulation contains no pharmaceutical agents and no materials of human, animal, or bacterial origin.

Ease of Use

Dynavisc gel is provided sterile and ready to use – no mixing required – and conveniently stored at room temperature. The prepackaged, thin flexible applicator allows for easy application, while the clear absorbable gel maintains operative site visibility.

Patient Satisfaction

By providing a temporary protective barrier between tissues during healing, Dynavisc is designed to minimize postoperative adhesion formation and associated complications, such as pain, joint stiffness, and restricted mobility. Reducing these complications may contribute to improved patient outcomes and satisfaction.

Handling and Placement

Dynavisc gel’s unique viscosity is flowable yet remains where applied throughout the healing process.

Connect with Fziomed

Contact us for additional information or to inquire about product availability in your country.

Dynavisc Tendon Protector is indicated for the management and protection of longitudinal tendon injuries in which there has been no substantial loss of tendon tissue. The device may also be used to manage and protect surrounding tissues during the surgical procedure to treat these injuries, such as ligament and skeletal muscle. In these procedures, the device may encounter implanted structures such as anchors, grafts, staples, or sutures.

References

  1. Bassetto F, et al. Efficacy and safety of Dynavisc gel in prevention of scar adhesions recurrence after flexor tendons tenolysis in zone 2. Multicenter retrospective cohort study. Ann Ital Chir 2023;94:529-536.
  2. Boumediane M, et al. Revision surgery for carpal tunnel syndrome: a retrospective study comparing the combination of Canaletto and Dynavisc gel versus Dynavisc gel alone. Hand Surg Rehabil 2021;40(1):57-63.
  3. Carmona A, et al. Revision surgery in carpal tunnel syndrome: a retrospective study comparing the Canaletto device alone versus a combination of Canaletto and Dynavisc gel. Hand Surg Rehabil 2019;38(1):52-58.
  4. Corduneanu-Luca AM et al. Improving flexor tendon gliding by using the combination of carboxymethylcellulose‑polyethylene oxide on murine model. Exp Ther Med 2022;23(1):105.

Last update: November 17, 2026